Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 23.65
-0.60 (-2.47%)
Aug 26, 2026, 1:50 PM CST
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 962.85 million as of August 25, 2026. Its market cap has decreased by -42.90% in one year.
Market Cap
962.85M
Enterprise Value
916.94M
Revenue
464.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.65
ChartMarket Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has decreased from 1.68B to 962.85M, a decrease of -42.71%. That is a compound annual growth rate of -9.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 1.12B | -55.44% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AViTA | 1.47B |
| Bioptik Technology Incorporation | 1.38B |
| Rossmax International | 1.09B |
| NaviFUS | 1.08B |
| S&S Healthcare Holding | 986.02M |
| Wiltrom | 979.59M |
| Cowealth Medical Holding | 906.34M |
| AmCad BioMed | 842.33M |